These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
697 related articles for article (PubMed ID: 24333218)
21. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells. Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038 [TBL] [Abstract][Full Text] [Related]
22. Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway. Yu M; Qi B; Xiaoxiang W; Xu J; Liu X Biomed Pharmacother; 2017 Jun; 90():677-685. PubMed ID: 28415048 [TBL] [Abstract][Full Text] [Related]
23. BDE-99 (2,2',4,4',5-pentabromodiphenyl ether) triggers epithelial-mesenchymal transition in colorectal cancer cells via PI3K/Akt/Snail signaling pathway. Wang F; Ruan XJ; Zhang HY Tumori; 2015; 101(2):238-45. PubMed ID: 25908029 [TBL] [Abstract][Full Text] [Related]
24. Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem-like phenotype through modulation of the PI3K/Akt/β-catenin/CBP pathway. He K; Xu T; Xu Y; Ring A; Kahn M; Goldkorn A Int J Cancer; 2014 Jan; 134(1):43-54. PubMed ID: 23784558 [TBL] [Abstract][Full Text] [Related]
25. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways. Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264 [TBL] [Abstract][Full Text] [Related]
26. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149 [TBL] [Abstract][Full Text] [Related]
27. EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. Haslehurst AM; Koti M; Dharsee M; Nuin P; Evans K; Geraci J; Childs T; Chen J; Li J; Weberpals J; Davey S; Squire J; Park PC; Feilotter H BMC Cancer; 2012 Mar; 12():91. PubMed ID: 22429801 [TBL] [Abstract][Full Text] [Related]
28. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway. Jiang P; Xu H; Xu C; Chen A; Chen L; Zhou M; Haq IU; Wu X; Mariyam Z; Feng Q Chem Biol Interact; 2018 Dec; 296():154-161. PubMed ID: 30291867 [TBL] [Abstract][Full Text] [Related]
29. Pellino-1 promotes lung carcinogenesis via the stabilization of Slug and Snail through K63-mediated polyubiquitination. Jeon YK; Kim CK; Hwang KR; Park HY; Koh J; Chung DH; Lee CW; Ha GH Cell Death Differ; 2017 Mar; 24(3):469-480. PubMed ID: 28009353 [TBL] [Abstract][Full Text] [Related]
30. Aspirin enhances cisplatin sensitivity of resistant non-small cell lung carcinoma stem-like cells by targeting mTOR-Akt axis to repress migration. Khan P; Bhattacharya A; Sengupta D; Banerjee S; Adhikary A; Das T Sci Rep; 2019 Nov; 9(1):16913. PubMed ID: 31729456 [TBL] [Abstract][Full Text] [Related]
31. Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT. Tan J; You Y; Xu T; Yu P; Wu D; Deng H; Zhang Y; Bie P Toxicol Lett; 2014 Jan; 224(1):7-15. PubMed ID: 24144893 [TBL] [Abstract][Full Text] [Related]
32. Snail regulates Nanog status during the epithelial-mesenchymal transition via the Smad1/Akt/GSK3β signaling pathway in non-small-cell lung cancer. Liu CW; Li CH; Peng YJ; Cheng YW; Chen HW; Liao PL; Kang JJ; Yeng MH Oncotarget; 2014 Jun; 5(11):3880-94. PubMed ID: 25003810 [TBL] [Abstract][Full Text] [Related]
33. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling. Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771 [TBL] [Abstract][Full Text] [Related]
34. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells. Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056 [TBL] [Abstract][Full Text] [Related]
35. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling. Geng F; Jiang Z; Song X; Zhou H; Zhao H Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479 [TBL] [Abstract][Full Text] [Related]
36. Hsp27 regulates EGF/β-catenin mediated epithelial to mesenchymal transition in prostate cancer. Cordonnier T; Bishop JL; Shiota M; Nip KM; Thaper D; Vahid S; Heroux D; Gleave M; Zoubeidi A Int J Cancer; 2015 Mar; 136(6):E496-507. PubMed ID: 25130271 [TBL] [Abstract][Full Text] [Related]
37. Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling. Kim IG; Kim SY; Choi SI; Lee JH; Kim KC; Cho EW Oncogene; 2014 Jul; 33(30):3908-17. PubMed ID: 24013232 [TBL] [Abstract][Full Text] [Related]
38. SET-mediated NDRG1 inhibition is involved in acquisition of epithelial-to-mesenchymal transition phenotype and cisplatin resistance in human lung cancer cell. Liu H; Gu Y; Yin J; Zheng G; Wang C; Zhang Z; Deng M; Liu J; Jia X; He Z Cell Signal; 2014 Dec; 26(12):2710-20. PubMed ID: 25152373 [TBL] [Abstract][Full Text] [Related]
39. Snail-induced epithelial-mesenchymal transition promotes cancer stem cell-like phenotype in head and neck cancer cells. Masui T; Ota I; Yook JI; Mikami S; Yane K; Yamanaka T; Hosoi H Int J Oncol; 2014 Mar; 44(3):693-9. PubMed ID: 24365974 [TBL] [Abstract][Full Text] [Related]
40. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells. Ma X; Wang B; Wang X; Luo Y; Fan W PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]